Company Data
SELLAS Life Sciences Group Inc.
Ticker
SLS
Current Price
$1.56 -7.14%
Market Cap
$141.7M
Price Target
Refer to Report
Volume
1.8M
52wk Range
$0.772 - $1.85
Overview
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.